This original article retrospectively analyzes the outcome of 359 patients after TEVAR at seven centers. All patients were stratified regarding the modified arch landing nomenclatur (MALAN). The rate of proximal endograft failure was significantly lower in patients with favorable landing area (MALAN 2/III and 3/III).
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Endovascular
September 3, 2020
August 20, 2020
This succinct article reviews the contemporary literature regarding sex differences in thoracic aortic disease including the epidemiology, biology, natural history, surgical management and outcomes.
August 19, 2020
The authors present a novel surgical treatment of a complex dialysis-dependent pediatric patient by transposing the left jugular vein to the right jugular vein when faced with left innominate vein occlusion refractory to attempts of transcatheter recanalization.
August 18, 2020
A review that may affect pharma strategy in the immediate future.
August 14, 2020
Haunschild et al. investigated the effect of cerebrospinal fluid pressure elevation on spinal cord perfusion in a large animal model. They could measure spinal cord perfusion by NIRS and microsphere injections. The spinal perfusion was significantly diminished during elevated cerebrospinal fluid pressure.
July 30, 2020
This video depicts the "hybrid" reconstruction utilized to reconstruct an emergent rupture of the distal aortic arch in a patient with a previous type I dissection repair.
July 8, 2020
Upchurch and coauthors have recently published the practice guidelines on thoracic endovascular aneurysm repair (TEVAR) in the mangement of thoracic aortic aneurysms.
July 8, 2020
Upchurch and coauthors have recently published the practice guidelines on thoracic endovascular aneurysm repair (TEVAR) in the mangement of thoracic aortic aneurysms.
June 12, 2020
The authors analyzed the volumes of thoracic endovascular aneurysm repair (TEVAR) for the treatment of descending thoracic aneurysms for Medicare patients over five years, comparing the proportion of cases to 30-day mortality.
June 11, 2020
As TAVR is used in progressively lower-risk cohorts, management of device failure will become increasingly important. This study reports the largest series of patients receiving a surgical reoperation after transcatheter aortic valve replacement (TAVR) using the STS Adult Cardiac Surgery Database.